Live Breaking News & Updates on Merck Sharp Dome

Stay updated with breaking news from Merck sharp dome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ASCO 2024: Belzutifan in Patients with Advanced Clear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 2 LITESPARK-013 Study

ASCO 2024, advanced clear cell renal cell carcinoma (ccRCC), Belzutifan, LITESPARK-013 Study, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI). ....

United States , Georgetown University , District Of Columbia , Michael Atkins , Michaelb Atkins , University Of Toronto , Georgetown Lombardi Comprehensive Cancer Center , Department Of Medical Oncology , Database Consortium , Georgetown University Medical Center , Merck Sharp Dome , Society Of Urologic Oncology , International Metastatic , American Society Of Clinical Oncology , Clinical Oncology , Annual Meeting , Deputy Director , Scholl Professor , Vice Chair , Medical Oncology , Rashid Sayyid , Urologic Oncology , Clinical Fellow ,